Hydroxamic Acid Ester Ruthenium Catalysts for Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for removing residual ruthenium impurities from reaction products in olefin metathesis reactions are inefficient and not suitable for pharmaceutical applications, with existing scavengers failing to meet industry standards for purity and simplicity.
Innovation Solution
Development of new metal complexes bearing hydroxamic acid ester groups as catalysts, which exhibit high affinity for adsorbents like silica gel, allowing for efficient and inexpensive purification of reaction products by facilitating the removal of residual ruthenium impurities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If classical non-tagged catalysts are applied, then metathesis reactions can be performed, but residual Ru removal is inefficient and requires complex purification protocols
Solution Approach 1:
The catalyst is pre-modified with a tagging group (such as a quaternary ammonium group or polar group) before the metathesis reaction. This preliminary modification enables the catalyst and its residues to be easily removed by simple filtration through adsorbents like silica gel, eliminating the need for complex purification protocols while achieving high product purity
Solution Approach 2:
A tagging group acts as an intermediary between the catalyst and the adsorbent (silica gel). This tagging group provides high affinity interaction with the adsorbent, allowing residual ruthenium to be efficiently captured and removed from the reaction mixture through simple filtration, thereby simplifying the purification process
2Manufacturing precision
If immobilized catalysts with onium groups are used, then residual Ru levels are reduced, but Ru levels remain too high for pharmaceutical application
Solution Approach 1:
The invention modifies the catalyst structure by introducing specific tagging groups (quaternary ammonium groups or polar groups with high affinity to silica gel) that enhance the catalyst's interaction with adsorbents. This parameter change in the catalyst's chemical properties enables much more efficient removal of residual Ru, achieving levels below 10 ppm that meet pharmaceutical application requirements
3Manufacturing precision
If polar uncharged complexes with high affinity to adsorbents are applied, then residual Ru removal is improved, but purification still does not meet pharmaceutical industry requirements
Solution Approach 1:
The invention creates a composite catalyst system by combining the metal complex with organic tagging groups (quaternary ammonium or polar groups). This composite structure provides both the catalytic activity of the metal complex and the high adsorbent affinity of the tagging group, enabling residual Ru removal to levels that comply with pharmaceutical standards through simple filtration
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of these complexes significantly reduces residual ruthenium levels in products, achieving purities up to 400 times lower than with classical catalysts, making the process more efficient and cost-effective for industrial applications, particularly in the pharmaceutical industry.
Implementation Method 1
complexes bearing hydroxamic acid ester group are applied as a catalysts... these complexes significantly reduces residual ruthenium levels in products... complexes bearing hydroxamic acid ester group... with high affinity to adsorbents
Data Source
AI summary
This disclosure relates to new metal complexes, such as compounds of Formula 1, and their application in olefin or alkyne metathesis and to methods of carrying out olefin metathesis reactions.